| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | semaphorin receptor activity | 3.07e-09 | 12 | 249 | 6 | GO:0017154 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | DHX36 MYH7 SETX ERCC6 ABCA13 ZGRF1 PSMC1 SPO11 ATP9B ABCA7 DNAH14 LONP1 ABCC8 DNAH6 RAD51D UBA3 ZNFX1 XRCC5 RUVBL1 ABCB10 IQCA1 IGHMBP2 ABCC12 DNAH11 | 8.36e-07 | 614 | 249 | 24 | GO:0140657 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | DHX36 MYH7 ERCC6 ABCA13 PSMC1 ATP9B ABCA7 LONP1 ABCC8 DNAH6 RAD51D XRCC5 RUVBL1 ABCB10 IQCA1 IGHMBP2 ABCC12 DNAH11 | 1.16e-05 | 441 | 249 | 18 | GO:0016887 |
| GeneOntologyMolecularFunction | DNA helicase activity | 1.18e-05 | 62 | 249 | 7 | GO:0003678 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 3.11e-05 | 127 | 249 | 9 | GO:0008094 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | ERBB4 FGFRL1 PLXND1 PLXNB2 ABCA7 GPR179 PGR OR51E1 OR14A2 ABCC8 GPR149 GLRA2 OR1E2 MERTK PLXNA1 PLXNA2 OR10A5 OR51A4 PLXNA3 AMHR2 GPR22 TAPT1 LPAR5 P2RY12 GPR34 SLAMF1 CELSR2 OR4A8 OR51Q1 OR52E8 TLR5 PLXNA4 SORCS3 OR4C12 OR51V1 | 3.22e-05 | 1353 | 249 | 35 | GO:0004888 |
| GeneOntologyMolecularFunction | peptidyltransferase activity | 3.73e-05 | 6 | 249 | 3 | GO:0000048 | |
| GeneOntologyMolecularFunction | leukotriene-C(4) hydrolase | 3.73e-05 | 6 | 249 | 3 | GO:0002951 | |
| GeneOntologyMolecularFunction | leukotriene C4 gamma-glutamyl transferase activity | 1.02e-04 | 8 | 249 | 3 | GO:0103068 | |
| GeneOntologyMolecularFunction | glutathione hydrolase activity | 1.52e-04 | 9 | 249 | 3 | GO:0036374 | |
| GeneOntologyMolecularFunction | 20-hydroxy-leukotriene B4 omega oxidase activity | 1.55e-04 | 2 | 249 | 2 | GO:0097258 | |
| GeneOntologyMolecularFunction | 20-aldehyde-leukotriene B4 20-monooxygenase activity | 1.55e-04 | 2 | 249 | 2 | GO:0097259 | |
| GeneOntologyMolecularFunction | arachidonate epoxygenase activity | 2.06e-04 | 24 | 249 | 4 | GO:0008392 | |
| GeneOntologyMolecularFunction | arachidonate monooxygenase activity | 3.31e-04 | 27 | 249 | 4 | GO:0008391 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 3.53e-04 | 49 | 249 | 5 | GO:0140359 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | DHX36 SETX ERCC6 ZGRF1 SPO11 RAD51D XRCC5 THAP9 LIG3 RUVBL1 IGHMBP2 | 4.73e-04 | 262 | 249 | 11 | GO:0140097 |
| GeneOntologyMolecularFunction | helicase activity | 8.44e-04 | 158 | 249 | 8 | GO:0004386 | |
| GeneOntologyMolecularFunction | aromatase activity | 9.12e-04 | 35 | 249 | 4 | GO:0070330 | |
| GeneOntologyMolecularFunction | omega peptidase activity | 9.51e-04 | 16 | 249 | 3 | GO:0008242 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | DHX36 SETX ERCC6 ZGRF1 ETF1 SPO11 GGT1 GGT3P RAD51D ZNFX1 XRCC5 THAP9 GGT2P LIG3 AGO1 RUVBL1 IGHMBP2 RNASET2 | 1.28e-03 | 645 | 249 | 18 | GO:0140640 |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 1.36e-03 | 18 | 249 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | alpha-tocopherol omega-hydroxylase activity | 1.51e-03 | 5 | 249 | 2 | GO:0052871 | |
| GeneOntologyMolecularFunction | calcium, potassium:sodium antiporter activity | 1.51e-03 | 5 | 249 | 2 | GO:0008273 | |
| GeneOntologyMolecularFunction | solute:potassium antiporter activity | 1.60e-03 | 19 | 249 | 3 | GO:0022821 | |
| GeneOntologyBiologicalProcess | regulation of axonogenesis | PLXND1 PLXNB2 SLIT2 KEL ULK1 PLXNA1 PLXNA2 PLXNA3 DIP2B ARHGAP4 SLIT1 PLXNA4 | 4.51e-06 | 192 | 252 | 12 | GO:0050770 |
| GeneOntologyCellularComponent | semaphorin receptor complex | 4.62e-09 | 13 | 252 | 6 | GO:0002116 | |
| GeneOntologyCellularComponent | Cul2-RING ubiquitin ligase complex | 2.48e-04 | 47 | 252 | 5 | GO:0031462 | |
| GeneOntologyCellularComponent | alpha-beta T cell receptor complex | 3.51e-04 | 12 | 252 | 3 | GO:0042105 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | CYBB SRXN1 CYP2C8 TMED6 CYP2C18 RPN2 WDR81 PTDSS2 SRPRB ELOVL2 SLC39A13 RYR3 SC5D NFE2L1 ULK1 FLRT2 ALG12 TAPT1 CYP4F2 APOB NCSTN MOSPD1 NBAS PIGT DHRS7 UBAC2 ABCC12 CYP4F3 LRBA LMBRD1 | 4.49e-04 | 1293 | 252 | 30 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | CYBB SRXN1 CYP2C8 TMED6 CYP2C18 RPN2 WDR81 PTDSS2 SRPRB ELOVL2 SLC39A13 RYR3 SC5D NFE2L1 ULK1 FLRT2 ALG12 TAPT1 CYP4F2 APOB NCSTN MOSPD1 NBAS PIGT DHRS7 UBAC2 ABCC12 CYP4F3 LRBA LMBRD1 | 4.85e-04 | 1299 | 252 | 30 | GO:0098827 |
| MousePheno | abnormal circulating glutathione level | 2.62e-05 | 5 | 195 | 3 | MP:0030652 | |
| MousePheno | increased circulating glutathione level | 2.62e-05 | 5 | 195 | 3 | MP:0030653 | |
| MousePheno | glutathionuria | 2.62e-05 | 5 | 195 | 3 | MP:0013730 | |
| MousePheno | increased glutathione level | 2.62e-05 | 5 | 195 | 3 | MP:0012606 | |
| MousePheno | aminoaciduria | 4.54e-05 | 29 | 195 | 5 | MP:0003311 | |
| MousePheno | decreased circulating cysteine level | 8.98e-05 | 7 | 195 | 3 | MP:0030626 | |
| MousePheno | failure of superovulation | 9.64e-05 | 18 | 195 | 4 | MP:0031422 | |
| MousePheno | abnormal copulation physiology | 1.21e-04 | 19 | 195 | 4 | MP:0031627 | |
| MousePheno | decreased cysteine level | 1.42e-04 | 8 | 195 | 3 | MP:0030623 | |
| MousePheno | epididymis hypoplasia | 1.42e-04 | 8 | 195 | 3 | MP:0004932 | |
| MousePheno | abnormal urine amino acid level | 1.66e-04 | 59 | 195 | 6 | MP:0011468 | |
| MousePheno | nervous | 2.11e-04 | 9 | 195 | 3 | MP:0008912 | |
| Domain | Plexin | 4.19e-10 | 9 | 248 | 6 | IPR031148 | |
| Domain | Plexin_cytopl | 4.19e-10 | 9 | 248 | 6 | PF08337 | |
| Domain | Plexin_cytoplasmic_RasGAP_dom | 4.19e-10 | 9 | 248 | 6 | IPR013548 | |
| Domain | ARM-type_fold | USP34 NOC2L NCBP1 RYR3 AP2A2 RRP12 UTP20 MYBBP1A RTTN ARFGEF2 ZNFX1 APOB HEATR5A HUWE1 IPO13 NUP188 LRBA STKLD1 XPO7 | 1.47e-07 | 339 | 248 | 19 | IPR016024 |
| Domain | Rho_GTPase_activation_prot | ARHGAP26 PLXND1 PLXNB2 PLXNA1 PLXNA2 PLXNA3 ARHGAP10 ARHGAP4 PLXNA4 ARHGAP27 | 2.59e-07 | 88 | 248 | 10 | IPR008936 |
| Domain | AAA+_ATPase | ABCA13 PSMC1 ABCA7 LONP1 ABCC8 DNAH6 RAD51D RUVBL1 ABCB10 IGHMBP2 ABCC12 DNAH11 | 5.08e-07 | 144 | 248 | 12 | IPR003593 |
| Domain | AAA | ABCA13 PSMC1 ABCA7 LONP1 ABCC8 DNAH6 RAD51D RUVBL1 ABCB10 IGHMBP2 ABCC12 DNAH11 | 5.08e-07 | 144 | 248 | 12 | SM00382 |
| Domain | IPT | 1.21e-06 | 27 | 248 | 6 | SM00429 | |
| Domain | SEMA | 2.88e-06 | 31 | 248 | 6 | PS51004 | |
| Domain | Semap_dom | 2.88e-06 | 31 | 248 | 6 | IPR001627 | |
| Domain | TIG | 2.88e-06 | 31 | 248 | 6 | PF01833 | |
| Domain | Sema | 2.88e-06 | 31 | 248 | 6 | SM00630 | |
| Domain | Sema | 2.88e-06 | 31 | 248 | 6 | PF01403 | |
| Domain | IPT | 3.50e-06 | 32 | 248 | 6 | IPR002909 | |
| Domain | Plexin_repeat | 3.50e-06 | 32 | 248 | 6 | IPR002165 | |
| Domain | PSI | 3.50e-06 | 32 | 248 | 6 | PF01437 | |
| Domain | PSI | 2.39e-05 | 44 | 248 | 6 | IPR016201 | |
| Domain | PSI | 3.10e-05 | 46 | 248 | 6 | SM00423 | |
| Domain | LRRCT | 5.96e-05 | 32 | 248 | 5 | PF01463 | |
| Domain | - | DHX36 SETX ERCC6 ABCA13 ZGRF1 NDST4 PSMC1 ABCA7 SRPRB DNAH14 EHD4 LONP1 ABCC8 IFI44L DNAH6 RAD51D ZNFX1 RUVBL1 ABCB10 IQCA1 IGHMBP2 ABCC12 ELP4 DNAH11 | 6.04e-05 | 746 | 248 | 24 | 3.40.50.300 |
| Domain | Ig_E-set | 7.42e-05 | 104 | 248 | 8 | IPR014756 | |
| Domain | PRAME_family | 1.01e-04 | 19 | 248 | 4 | IPR026271 | |
| Domain | L_dom-like | ERBB4 PRAMEF25 IGSF10 SLIT2 FLRT2 NLRX1 PRAMEF15 FBXL17 PRAMEF4 SLIT1 TLR5 PRAMEF27 LRRC36 TPBG | 1.32e-04 | 328 | 248 | 14 | IPR032675 |
| Domain | P-loop_NTPase | DHX36 MYH7 SETX ERCC6 ABCA13 ZGRF1 NDST4 PSMC1 ABCA7 SRPRB DNAH14 EHD4 LONP1 ABCC8 IFI44L DNAH6 RAD51D ZNFX1 RUVBL1 ABCB10 IQCA1 IGHMBP2 ABCC12 ELP4 DNAH11 | 1.68e-04 | 848 | 248 | 25 | IPR027417 |
| Domain | Rab_escort | 1.76e-04 | 2 | 248 | 2 | IPR001738 | |
| Domain | ARM-like | SETX AP2A2 RRP12 UTP20 RTTN ARFGEF2 HEATR5A HUWE1 IPO13 LRBA STKLD1 XPO7 | 2.76e-04 | 270 | 248 | 12 | IPR011989 |
| Domain | LamG | 2.82e-04 | 44 | 248 | 5 | SM00282 | |
| Domain | Fol_N | 3.53e-04 | 11 | 248 | 3 | IPR003645 | |
| Domain | FOLN | 3.53e-04 | 11 | 248 | 3 | SM00274 | |
| Domain | - | PRAMEF25 IGSF10 SLIT2 FLRT2 NLRX1 PRAMEF15 FBXL17 PRAMEF4 SLIT1 TLR5 PRAMEF27 LRRC36 TPBG | 3.80e-04 | 321 | 248 | 13 | 3.80.10.10 |
| Domain | ABC_TRANSPORTER_2 | 4.26e-04 | 48 | 248 | 5 | PS50893 | |
| Domain | ABC_tran | 4.26e-04 | 48 | 248 | 5 | PF00005 | |
| Domain | ABC_TRANSPORTER_1 | 4.69e-04 | 49 | 248 | 5 | PS00211 | |
| Domain | hEGF | 4.83e-04 | 28 | 248 | 4 | PF12661 | |
| Domain | ABC_transporter-like | 5.16e-04 | 50 | 248 | 5 | IPR003439 | |
| Domain | ZnF_TTF | 5.22e-04 | 3 | 248 | 2 | SM00597 | |
| Domain | Znf_TTF | 5.22e-04 | 3 | 248 | 2 | IPR006580 | |
| Domain | MT | 7.56e-04 | 14 | 248 | 3 | PF12777 | |
| Domain | AAA_8 | 7.56e-04 | 14 | 248 | 3 | PF12780 | |
| Domain | Dynein_heavy_chain_D4_dom | 7.56e-04 | 14 | 248 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 7.56e-04 | 14 | 248 | 3 | IPR024743 | |
| Domain | DHC_fam | 9.35e-04 | 15 | 248 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 9.35e-04 | 15 | 248 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 9.35e-04 | 15 | 248 | 3 | IPR004273 | |
| Domain | Laminin_G | 1.02e-03 | 58 | 248 | 5 | IPR001791 | |
| Domain | GDP_dissociation_inhibitor | 1.04e-03 | 4 | 248 | 2 | IPR018203 | |
| Domain | GDI | 1.04e-03 | 4 | 248 | 2 | PF00996 | |
| Domain | Cys-rich_flank_reg_C | 1.27e-03 | 90 | 248 | 6 | IPR000483 | |
| Domain | LRRCT | 1.27e-03 | 90 | 248 | 6 | SM00082 | |
| Domain | LAM_G_DOMAIN | 1.57e-03 | 38 | 248 | 4 | PS50025 | |
| Pathway | REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION | 3.59e-06 | 9 | 187 | 4 | MM15030 | |
| Pathway | REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX | 1.67e-05 | 25 | 187 | 5 | MM14858 | |
| Pathway | REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION | 2.71e-05 | 14 | 187 | 4 | MM15029 | |
| Pathway | REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION | 2.71e-05 | 14 | 187 | 4 | M7578 | |
| Pathway | REACTOME_CRMPS_IN_SEMA3A_SIGNALING | 3.65e-05 | 15 | 187 | 4 | MM15031 | |
| Pathway | REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION | 4.82e-05 | 16 | 187 | 4 | M16498 | |
| Pathway | REACTOME_CRMPS_IN_SEMA3A_SIGNALING | 4.82e-05 | 16 | 187 | 4 | M8245 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_LIPOXYGENASES_LOX | 6.83e-05 | 33 | 187 | 5 | MM15963 | |
| Pathway | REACTOME_OTHER_SEMAPHORIN_INTERACTIONS | 9.94e-05 | 19 | 187 | 4 | M10959 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 1.52e-04 | 61 | 187 | 6 | MM14861 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY | 1.82e-04 | 9 | 187 | 3 | M39819 | |
| Pathway | KEGG_ABC_TRANSPORTERS | 2.78e-04 | 44 | 187 | 5 | M11911 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | USP34 DHX36 RPN2 PSMC1 PTDSS2 PLXND1 PLXNB2 ABCA7 SRPRB SLC39A13 IGSF10 SERPINE2 SC5D RRP12 CPSF1 TMEM131L UTP20 TMCO3 ALG12 PLXNA1 PLXNA3 COL15A1 ARFGEF2 LAMC1 NCSTN AIP COLGALT1 PIGT GTF3C1 RUVBL1 CELSR2 CGREF1 IPO13 UBAC2 | 2.08e-11 | 1201 | 256 | 34 | 35696571 |
| Pubmed | Transmembrane semaphorin signalling controls laminar stratification in the mammalian retina. | 1.34e-10 | 12 | 256 | 6 | 21270798 | |
| Pubmed | 2.47e-10 | 13 | 256 | 6 | 10520995 | ||
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | USP34 SRXN1 ACO2 PTDSS2 PLXND1 GGT1 STAT6 PASK SERPINE2 C5 PLXNA1 SELENBP1 TAPT1 LMCD1 NPEPPS NLRX1 ARFGEF2 APOB HUWE1 PIGT CELSR2 ABCB10 TAMM41 DHRS7 IPO13 MFSD8 CLINT1 NUP188 LRBA TPBG | 3.60e-10 | 1061 | 256 | 30 | 33845483 |
| Pubmed | 1.14e-09 | 8 | 256 | 5 | 15661641 | ||
| Pubmed | 1.73e-09 | 17 | 256 | 6 | 11683995 | ||
| Pubmed | Semaphorin signaling facilitates cleft formation in the developing salivary gland. | 1.73e-09 | 17 | 256 | 6 | 17626059 | |
| Pubmed | 1.90e-09 | 47 | 256 | 8 | 35462405 | ||
| Pubmed | 2.87e-09 | 4 | 256 | 4 | 11306810 | ||
| Pubmed | PlexinA polymorphisms mediate the developmental trajectory of human corpus callosum microstructure. | 2.87e-09 | 4 | 256 | 4 | 25518740 | |
| Pubmed | 1.58e-08 | 12 | 256 | 5 | 25839327 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | DHX36 MCMBP RPN2 NOC2L ACO2 ETF1 PSMC1 NCBP1 ANKHD1 DCTN1 SRPRB EHD4 LONP1 FASN AP2A2 RRP12 CPSF1 UTP20 BSN CLUH PLXNA1 MYBBP1A NPEPPS APOB HUWE1 COLGALT1 XRCC5 LIG3 GTF3C1 RUVBL1 CLINT1 NUP188 | 2.34e-08 | 1425 | 256 | 32 | 30948266 |
| Pubmed | 4.93e-08 | 28 | 256 | 6 | 18617019 | ||
| Pubmed | Expression of the semaphorins Sema 3D and Sema 3F in the developing parathyroid and thymus. | 8.49e-08 | 16 | 256 | 5 | 18489001 | |
| Pubmed | Semaphorin-6A controls guidance of corticospinal tract axons at multiple choice points. | 9.86e-08 | 7 | 256 | 4 | 19063725 | |
| Pubmed | Increased proximal bifurcation of CA1 pyramidal apical dendrites in sema3A mutant mice. | 9.86e-08 | 7 | 256 | 4 | 19655386 | |
| Pubmed | USP34 DHX36 RPN2 NOC2L NCBP1 ANKHD1 LONP1 FASN UBR5 RRP12 CPSF1 UTP20 CLUH MYBBP1A NPEPPS HUWE1 XRCC5 GTF3C1 NUP188 XPO7 | 1.01e-07 | 653 | 256 | 20 | 22586326 | |
| Pubmed | 1.09e-07 | 52 | 256 | 7 | 26633812 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | FAM47A MCMBP NDUFS7 SETX PSMC1 NCBP1 CHML DNAH14 IGSF10 CPSF1 UTP20 OR51A4 LPAR5 HUWE1 XRCC5 LIG3 LOXHD1 GTF3C1 PLXNA4 NUP188 ELP4 | 1.56e-07 | 736 | 256 | 21 | 29676528 |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | NDUFS7 RPN2 NOC2L SRM PSMC1 PTDSS2 PLXNB2 SRPRB SLIT2 FASN SC5D UBR5 RRP12 PGRMC2 UTP20 MYBBP1A NCSTN HUWE1 ABCB10 DHRS7 UBAC2 CLINT1 NUP188 XPO7 | 1.59e-07 | 942 | 256 | 24 | 31073040 |
| Pubmed | RPN2 PSMC1 ITGAX DCTN1 EHD4 LONP1 FASN UBR5 PGRMC2 ALG12 DIP2B MYBBP1A ARFGEF2 NCSTN HUWE1 COLGALT1 XRCC5 NBAS PIGT GTF3C1 DHRS7 IGHMBP2 CLINT1 NUP188 LRBA CMTM7 LMBRD1 | 1.80e-07 | 1168 | 256 | 27 | 19946888 | |
| Pubmed | Integration of opposing semaphorin guidance cues in cortical axons. | 1.96e-07 | 8 | 256 | 4 | 22368082 | |
| Pubmed | 3.51e-07 | 9 | 256 | 4 | 19909241 | ||
| Pubmed | 3.94e-07 | 3 | 256 | 3 | 27397516 | ||
| Pubmed | 3.94e-07 | 3 | 256 | 3 | 8806646 | ||
| Pubmed | 3.94e-07 | 3 | 256 | 3 | 18625214 | ||
| Pubmed | Differential expression of plexin-A subfamily members in the mouse nervous system. | 3.94e-07 | 3 | 256 | 3 | 11241833 | |
| Pubmed | Different gamma-glutamyl transpeptidase mRNAs are expressed in human liver and kidney. | 3.94e-07 | 3 | 256 | 3 | 2573352 | |
| Pubmed | Plexin A3 and plexin A4 convey semaphorin signals during facial nerve development. | 5.82e-07 | 10 | 256 | 4 | 18804103 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | NOC2L PSMC1 NCBP1 PLXNB2 SRPRB EHD4 SLIT2 LONP1 FASN UBR5 RRP12 PGRMC2 CPSF1 UTP20 MYBBP1A NPEPPS LAMC1 HUWE1 XRCC5 LIG3 GTF3C1 RUVBL1 NUP188 XPO7 | 7.07e-07 | 1024 | 256 | 24 | 24711643 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MYCL USP34 SRXN1 ARHGAP26 FGFRL1 PLXND1 ANKHD1 DYSF PLXNB2 DCTN1 ABCA7 FASN RRP12 CPSF1 ULK1 PLXNA1 PLXNA3 LPAR5 NLRX1 RTTN ARFGEF2 HUWE1 CELSR2 NUP188 LRBA | 7.79e-07 | 1105 | 256 | 25 | 35748872 |
| Pubmed | A radial axis defined by semaphorin-to-neuropilin signaling controls pancreatic islet morphogenesis. | 7.88e-07 | 24 | 256 | 5 | 28893946 | |
| Pubmed | Genome-wide association of lipid-lowering response to statins in combined study populations. | 1.06e-06 | 72 | 256 | 7 | 20339536 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | USP34 MCMBP RPN2 ARHGAP26 PSMC1 ANKHD1 SRPRB PASK FASN UBR5 TMEM131L CLUH DIP2B ARHGAP10 NPEPPS LAMC1 NCSTN AIP HUWE1 FUOM GTF3C1 UBAC2 NUP188 | 1.07e-06 | 974 | 256 | 23 | 28675297 |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | USP34 RPN2 NOC2L FGFRL1 NCBP1 PLXNB2 SRPRB FASN AP2A2 RRP12 PGRMC2 CLUH MYBBP1A C6orf89 LAMC1 NCSTN XRCC5 PIGT FAM111A ABCB10 DHRS7 UBAC2 ZMYM1 NUP188 TPBG XPO7 | 1.09e-06 | 1203 | 256 | 26 | 29180619 |
| Pubmed | On and off retinal circuit assembly by divergent molecular mechanisms. | 1.36e-06 | 12 | 256 | 4 | 24179230 | |
| Pubmed | 1.36e-06 | 12 | 256 | 4 | 23991118 | ||
| Pubmed | 1.36e-06 | 12 | 256 | 4 | 31690636 | ||
| Pubmed | 1.36e-06 | 12 | 256 | 4 | 28407732 | ||
| Pubmed | 1.57e-06 | 4 | 256 | 3 | 10725340 | ||
| Pubmed | A family of transmembrane proteins with homology to the MET-hepatocyte growth factor receptor. | 1.57e-06 | 4 | 256 | 3 | 8570614 | |
| Pubmed | 1.95e-06 | 13 | 256 | 4 | 11604131 | ||
| Pubmed | Semaphorin3A, Neuropilin-1, and PlexinA1 are required for lymphatic valve formation. | 1.95e-06 | 13 | 256 | 4 | 22723296 | |
| Pubmed | Functional assembly of accessory optic system circuitry critical for compensatory eye movements. | 1.95e-06 | 13 | 256 | 4 | 25959730 | |
| Pubmed | LRF maintains genome integrity by regulating the non-homologous end joining pathway of DNA repair. | 1.99e-06 | 79 | 256 | 7 | 26446488 | |
| Pubmed | USP34 DHX36 SETX ARHGAP26 PLXND1 ANKHD1 STAB1 PASK TMEM131L BSN SYT13 RALGDS NCSTN ARHGAP4 IPO13 NUP188 | 2.33e-06 | 529 | 256 | 16 | 14621295 | |
| Pubmed | A midline switch of receptor processing regulates commissural axon guidance in vertebrates. | 2.71e-06 | 14 | 256 | 4 | 20159958 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | RPN2 FASN RRP12 UTP20 MYBBP1A ARFGEF2 LAMC1 ZNFX1 XRCC5 NBAS | 2.83e-06 | 202 | 256 | 10 | 33005030 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | DHX36 SETX ERCC6 NOC2L ACO2 SRM PSMC1 ANKHD1 DCTN1 SRPRB EHD4 STK4 LONP1 FASN AP2A2 UBR5 RRP12 CPSF1 UTP20 MYBBP1A NPEPPS HUWE1 COLGALT1 XRCC5 LIG3 GTF3C1 RUVBL1 | 2.98e-06 | 1353 | 256 | 27 | 29467282 |
| Pubmed | USP34 RPN2 NOC2L PSMC1 NCBP1 GCH1 SRPRB EHD4 LONP1 FASN AP2A2 UBR5 RRP12 PGRMC2 IFI44L CORO2A NPEPPS LAMC1 HUWE1 COLGALT1 XRCC5 NBAS LIG3 PIGT GTF3C1 IPO13 CLINT1 NUP188 | 3.17e-06 | 1440 | 256 | 28 | 30833792 | |
| Pubmed | 3.67e-06 | 15 | 256 | 4 | 17010969 | ||
| Pubmed | 3.67e-06 | 15 | 256 | 4 | 36028553 | ||
| Pubmed | 3.90e-06 | 5 | 256 | 3 | 23615310 | ||
| Pubmed | 3.90e-06 | 5 | 256 | 3 | 11003618 | ||
| Pubmed | 3.90e-06 | 5 | 256 | 3 | 25313870 | ||
| Pubmed | 3.90e-06 | 5 | 256 | 3 | 10392451 | ||
| Pubmed | 3.90e-06 | 5 | 256 | 3 | 19850887 | ||
| Pubmed | Reversible skeletal abnormalities in gamma-glutamyl transpeptidase-deficient mice. | 3.90e-06 | 5 | 256 | 3 | 12810527 | |
| Pubmed | Growth retardation and cysteine deficiency in gamma-glutamyl transpeptidase-deficient mice. | 3.90e-06 | 5 | 256 | 3 | 8755578 | |
| Pubmed | Reproductive defects in gamma-glutamyl transpeptidase-deficient mice. | 3.90e-06 | 5 | 256 | 3 | 11089562 | |
| Pubmed | 3.90e-06 | 5 | 256 | 3 | 26977590 | ||
| Pubmed | Gamma-glutamyl transferase deficiency results in lung oxidant stress in normoxia. | 3.90e-06 | 5 | 256 | 3 | 12225953 | |
| Pubmed | 3.90e-06 | 5 | 256 | 3 | 7775425 | ||
| Pubmed | 3.90e-06 | 5 | 256 | 3 | 9139708 | ||
| Pubmed | 3.90e-06 | 5 | 256 | 3 | 20622017 | ||
| Pubmed | Accelerated methylmercury elimination in gamma-glutamyl transpeptidase-deficient mice. | 3.90e-06 | 5 | 256 | 3 | 9546365 | |
| Pubmed | 3.90e-06 | 5 | 256 | 3 | 7485380 | ||
| Pubmed | Accumulation of DNA damage in the organs of mice deficient in gamma-glutamyltranspeptidase. | 3.90e-06 | 5 | 256 | 3 | 10751614 | |
| Pubmed | Type VI RNA is the major gamma-glutamyl transpeptidase RNA in the mouse small intestine. | 3.90e-06 | 5 | 256 | 3 | 7523374 | |
| Pubmed | Cardio-reno-hepatic interactions in acute heart failure: the role of γ-glutamyl transferase. | 3.90e-06 | 5 | 256 | 3 | 24698228 | |
| Pubmed | 3.90e-06 | 5 | 256 | 3 | 10474818 | ||
| Pubmed | Lung lining fluid glutathione attenuates IL-13-induced asthma. | 3.90e-06 | 5 | 256 | 3 | 18063838 | |
| Pubmed | 3.90e-06 | 5 | 256 | 3 | 10940879 | ||
| Pubmed | Cataract development in gamma-glutamyl transpeptidase-deficient mice. | 3.90e-06 | 5 | 256 | 3 | 11095909 | |
| Pubmed | 3.90e-06 | 5 | 256 | 3 | 7641802 | ||
| Pubmed | 3.90e-06 | 5 | 256 | 3 | 9627710 | ||
| Pubmed | 3.90e-06 | 5 | 256 | 3 | 12453183 | ||
| Pubmed | 3.90e-06 | 5 | 256 | 3 | 2891746 | ||
| Pubmed | 3.90e-06 | 5 | 256 | 3 | 28660214 | ||
| Pubmed | Bleomycin-induced pulmonary fibrosis is attenuated in gamma-glutamyl transpeptidase-deficient mice. | 3.90e-06 | 5 | 256 | 3 | 12468440 | |
| Pubmed | Cloning of cDNA and genomic structure of the mouse gamma-glutamyl transpeptidase-encoding gene. | 3.90e-06 | 5 | 256 | 3 | 8566783 | |
| Pubmed | 3.90e-06 | 5 | 256 | 3 | 30591459 | ||
| Pubmed | 3.90e-06 | 5 | 256 | 3 | 11795900 | ||
| Pubmed | Inhibiting lung lining fluid glutathione metabolism with GGsTop as a novel treatment for asthma. | 3.90e-06 | 5 | 256 | 3 | 25132819 | |
| Pubmed | Characterization of the dwg mutations: dwg and dwg(Bayer) are new mutant alleles of the Ggt1 gene. | 3.90e-06 | 5 | 256 | 3 | 19760322 | |
| Pubmed | 4.59e-06 | 126 | 256 | 8 | 16284245 | ||
| Pubmed | 4.87e-06 | 16 | 256 | 4 | 17356169 | ||
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | DHX36 NDUFS7 ACO2 PSMC1 CHML PLXNB2 SRPRB ELOVL2 EHD4 LONP1 RRP12 PGRMC2 CPSF1 FASTKD3 CLUH DIP2B MYBBP1A COL15A1 SYNM AIP HUWE1 XRCC5 NBAS ABCB10 DHRS7 UBAC2 NUP188 RBFA | 6.46e-06 | 1496 | 256 | 28 | 32877691 |
| Pubmed | 7.76e-06 | 6 | 256 | 3 | 14634009 | ||
| Pubmed | Sequence and evolution of the human T-cell antigen receptor beta-chain genes. | 7.76e-06 | 6 | 256 | 3 | 3860845 | |
| Pubmed | Six mRNAs with different 5' ends are encoded by a single gamma-glutamyltransferase gene in mouse. | 7.76e-06 | 6 | 256 | 3 | 8101000 | |
| Pubmed | Mapping of human gamma-glutamyl transpeptidase genes on chromosome 22 and other human autosomes. | 7.76e-06 | 6 | 256 | 3 | 8104871 | |
| Pubmed | 7.76e-06 | 6 | 256 | 3 | 11463821 | ||
| Pubmed | 7.76e-06 | 6 | 256 | 3 | 25326709 | ||
| Pubmed | 7.76e-06 | 6 | 256 | 3 | 12511607 | ||
| Pubmed | 7.76e-06 | 6 | 256 | 3 | 12163373 | ||
| Pubmed | Expression and function of semaphorin 3A and its receptors in human monocyte-derived macrophages. | 7.76e-06 | 6 | 256 | 3 | 19480842 | |
| Pubmed | 7.76e-06 | 6 | 256 | 3 | 22242126 | ||
| Pubmed | 7.76e-06 | 6 | 256 | 3 | 17363454 | ||
| Pubmed | 7.76e-06 | 6 | 256 | 3 | 8663190 | ||
| Interaction | SEMA5A interactions | 7.49e-07 | 7 | 247 | 4 | int:SEMA5A | |
| Cytoband | 1p36.21 | 2.80e-05 | 63 | 256 | 5 | 1p36.21 | |
| Cytoband | 17p13.3 | 1.39e-04 | 88 | 256 | 5 | 17p13.3 | |
| GeneFamily | Plexins | 6.86e-11 | 9 | 178 | 6 | 683 | |
| GeneFamily | PRAME family | 9.72e-08 | 24 | 178 | 6 | 686 | |
| GeneFamily | UPF1 like RNA helicases | 2.84e-06 | 11 | 178 | 4 | 1169 | |
| GeneFamily | CD molecules|Gamma-glutamyltransferases | 2.50e-04 | 13 | 178 | 3 | 564 | |
| GeneFamily | Dyneins, axonemal | 5.76e-04 | 17 | 178 | 3 | 536 | |
| GeneFamily | Olfactory receptors, family 51 | 9.07e-04 | 44 | 178 | 4 | 164 | |
| GeneFamily | Transmembrane BAX inhibitor motif containing | 1.41e-03 | 6 | 178 | 2 | 1215 | |
| GeneFamily | Rho GTPase activating proteins|BCH domain containing | 1.47e-03 | 50 | 178 | 4 | 721 | |
| GeneFamily | AAA ATPases | 1.83e-03 | 53 | 178 | 4 | 413 | |
| GeneFamily | Cation channels sperm associated | 1.96e-03 | 7 | 178 | 2 | 186 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 3.32e-03 | 9 | 178 | 2 | 1230 | |
| Coexpression | GSE17721_0.5H_VS_12H_POLYIC_BMDC_UP | ACO2 NCBP1 FASN SC5D CPSF1 C8G SELENBP1 C6orf89 FUOM CATSPER1 CELSR2 | 3.94e-06 | 200 | 251 | 11 | M4084 |
| ToppCell | Immune-enucleated_erythrocyte|World / Lineage, Cell type, age group and donor | SLC22A23 BEST3 TMEM131L KEL SELENBP1 MOSPD1 ABCB10 GYPB RAPGEF2 XPO7 | 1.33e-07 | 186 | 256 | 10 | f9d5ec5cc8fd6e63bf25abe390307ec8a4a2d5a3 |
| ToppCell | Fetal_29-31_weeks-Immune-enucleated_erythrocyte|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | SLC22A23 BEST3 TMEM131L KEL SELENBP1 MOSPD1 ABCB10 GYPB RAPGEF2 XPO7 | 1.54e-07 | 189 | 256 | 10 | 1900e574870fc647bfa11c732a72f3d38aab717c |
| ToppCell | E16.5-samps-Myeloid-Fetal_macrophage-macrophage_-_intermediate_-_unactivated|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.24e-07 | 150 | 256 | 9 | 60fdd266aaca1b589b9a77465a4a7fad4921339a | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | MORC1 CYBB ITGAX SLC12A5 STAB1 MERTK LPAR5 P2RY12 GPR34 ARHGAP4 | 2.60e-07 | 200 | 256 | 10 | 27f498bcd706d0751091662996795b5270e46f14 |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_T-T_NK-CD8_T_cell|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.19e-06 | 183 | 256 | 9 | bbe389d5bee8754210f5ec4039a5ecba6a3977a9 | |
| ToppCell | Fetal_29-31_weeks-Immune-enucleated_erythrocyte-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | SLC22A23 BEST3 TMEM131L KEL SELENBP1 ABCB10 GYPB RAPGEF2 XPO7 | 1.31e-06 | 185 | 256 | 9 | e8f7da9641b6cf1db1093b4f301ce828fd3a529c |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.78e-06 | 192 | 256 | 9 | c0e59e642b42c055cf73d029cf54d07d9b719359 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.78e-06 | 192 | 256 | 9 | 1ee4783051ec94ea94600f040edcb385fc4289f1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.78e-06 | 192 | 256 | 9 | 25cb6cc6cbf8dc20139d938adfc02ed7a8c3dfb6 | |
| ToppCell | wk_08-11-Hematologic-Meg-ery-Definitive_erythroblast|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.85e-06 | 193 | 256 | 9 | be75abfdf5301cf33df8ee9ed92504d44fdf19a6 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW08-Myeloid-Microglia|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 2.10e-06 | 196 | 256 | 9 | 89a0ccd0684777927d99d5fc5b7c498f3f124250 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW08-Myeloid|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 2.10e-06 | 196 | 256 | 9 | 91a8c4798572d6c1f03cef5e8e5464ed0046c7cf | |
| ToppCell | distal-Hematologic-IGSF21+_Dendritic|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.19e-06 | 197 | 256 | 9 | a357ee2ba9100dfaeba9ecae8138a2776bb54b0b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.19e-06 | 197 | 256 | 9 | 412cb5f37df57121ddd1492021445479c7cbccbf | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.38e-06 | 199 | 256 | 9 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | wk_20-22-Hematologic-Myeloid-SPP1+_Mac|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | CYBB BCAT1 SLC12A5 STAB1 MERTK GPR34 COLGALT1 ARHGAP4 RNASET2 | 2.38e-06 | 199 | 256 | 9 | 7c19f1b1f4369edd035ca9cdcf4e653771fc4648 |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_I-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | WDR81 ITGAX P2RY12 GPR34 FUOM ANKRD36B ARHGAP4 RNASET2 ARHGAP27 | 2.48e-06 | 200 | 256 | 9 | 80e0483d5ab0c6213aae0ec62619f57e6ec0e4c2 |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.30e-06 | 155 | 256 | 8 | 93bfcf5c12cbb61a1e0444312afd2aa411a8bf50 | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Myeloid|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.18e-06 | 117 | 256 | 7 | f0c738b6b850733f9af68704172554177a1c1198 | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Myeloid-Megakaryocyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.18e-06 | 117 | 256 | 7 | b5cb9d69ddd42331134f7e4bd51bd1c31030893c | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)-D122|Adult / Lineage, Cell type, age group and donor | 5.47e-06 | 166 | 256 | 8 | be284e2e596390f05305c7bcfc316f87b963fc0b | |
| ToppCell | COVID-19-lung-RBC|lung / Disease (COVID-19 only), tissue and cell type | 6.81e-06 | 171 | 256 | 8 | 0e8d63c8fbccdda4f1ef00de00667a50464b104b | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 6.83e-06 | 122 | 256 | 7 | 37612ad087d9c11d4a3466244ab36224de31930b | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-GrB-secreting_B_cells|normal_Lymph_Node / Location, Cell class and cell subclass | 8.06e-06 | 175 | 256 | 8 | 29fbdfe1d3bfcb063be2bced0128a33176c5b78f | |
| ToppCell | 390C-Lymphocytic-ILC-ILC-1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 9.51e-06 | 179 | 256 | 8 | 3edcd1356e49b1f5514c585861999e079ca5e579 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.90e-06 | 180 | 256 | 8 | c6030e725e3d86d5d74a1676330c77ffeceb324f | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Endothelial_Myeloid|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.31e-05 | 187 | 256 | 8 | 23a42c172d5cc36cb8793c0bc2ce357c6c8e5d39 | |
| ToppCell | severe_influenza-RBC|World / disease group, cell group and cell class (v2) | 1.31e-05 | 187 | 256 | 8 | f846750575f318503d21ade30f5bfd2e1d4c84af | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Endothelial_Myeloid-Micro-Microglia|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.36e-05 | 188 | 256 | 8 | 26c0a94951236a5d17a169920b0a8a9d0dd7d0ed | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Endothelial_Myeloid|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.36e-05 | 188 | 256 | 8 | c65fb9a3c910dd6166853f4f3a2f2c2411ccf03b | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Endothelial_Myeloid-Micro-Microglia-Micro_L1-6_C1QC|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.36e-05 | 188 | 256 | 8 | af300574c4e95505f56bf716bcee1e4777944e8e | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Endothelial_Myeloid-Micro|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.36e-05 | 188 | 256 | 8 | e169e9bb85892e52880ee949d0f691d0ea0c8dc9 | |
| ToppCell | Influenza_Severe-RBC|World / Disease group and Cell class | 1.36e-05 | 188 | 256 | 8 | f0438e6a77ee1f0456cb65926685266fff470983 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.47e-05 | 190 | 256 | 8 | 656483751e4bf137e4e4bfb2a03a478a8f7fcb63 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.47e-05 | 190 | 256 | 8 | 0fea33f2dc1efa23aaa2da1c318482a52a313ff1 | |
| ToppCell | 21-Trachea-Endothelial-Endothelial|Trachea / Age, Tissue, Lineage and Cell class | 1.47e-05 | 190 | 256 | 8 | 08437396a98ca9526f69c3a74bbf2929f3c68b8e | |
| ToppCell | 21-Trachea-Endothelial|Trachea / Age, Tissue, Lineage and Cell class | 1.47e-05 | 190 | 256 | 8 | bce09634acbc2cfd53666328e8aed8bf8835f845 | |
| ToppCell | 10x5'v1-week_17-19-Endothelial-stroma-proliferating_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.52e-05 | 191 | 256 | 8 | dc9e5eb6aa31b8d79aeec33e59b9138dfb469a3b | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_INF-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.58e-05 | 192 | 256 | 8 | 935a4a36881a9fa4daa02cba96af07f6686ed8d6 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.58e-05 | 192 | 256 | 8 | 69758a256386a6ed3a6e2c94c55d59baa34892d7 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-05 | 193 | 256 | 8 | 52e918884877b6659cdca0496390e440f73694a9 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.64e-05 | 193 | 256 | 8 | 1db487e5f81849740d57cc3e2b5739e8f7581efb | |
| ToppCell | 367C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.70e-05 | 194 | 256 | 8 | e3688f4252aae5f849f025d7f453ff4c0c14590b | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage-Interstitial_macrophage_perivascular-Interstitial_macrophage_perivascular_L.1.2.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.70e-05 | 194 | 256 | 8 | 7b6a34d1f8922b71dcc931421666c1822cec8345 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage-Interstitial_macrophage_perivascular|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.70e-05 | 194 | 256 | 8 | 435406ebe626c702f7d5a99a3d68ee85aa09be95 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.70e-05 | 194 | 256 | 8 | 48c37251518f96524807b5bd1bbc2820637666ad | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.70e-05 | 194 | 256 | 8 | e55dc30e200c9f576804acb642175eb4fa9146b5 | |
| ToppCell | COVID-19-Myeloid-Monocyte-derived_macrophages|COVID-19 / group, cell type (main and fine annotations) | 1.77e-05 | 195 | 256 | 8 | c172c5599379c29123340621a36bfb1fc90c2115 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.77e-05 | 195 | 256 | 8 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.77e-05 | 195 | 256 | 8 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-05 | 196 | 256 | 8 | 8ad8efb631164b46f0c082572270188e5ead20bf | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.83e-05 | 196 | 256 | 8 | 3f065139f76ed048875cd6c03aa02300db2b6574 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-05 | 196 | 256 | 8 | 9606ea7e42f707e69ea891b3521037613b9675f5 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-tip_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.90e-05 | 197 | 256 | 8 | b212ff28ca2d1fea4140f186ab90941bdca21249 | |
| ToppCell | distal-3-Hematologic-IGSF21+_Dendritic|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.90e-05 | 197 | 256 | 8 | 52e9dc35dd8cc2605fa4894bb16bb5c6086faa76 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.90e-05 | 197 | 256 | 8 | cd509e49bbdbf991cc5913960ff3ef275ad40628 | |
| ToppCell | COVID-19|World / Condition, Lineage and Cell class | 1.90e-05 | 197 | 256 | 8 | 228f641d79282cc3dc51b95a1f4b0cccfc200735 | |
| ToppCell | wk_20-22-Hematologic-Myeloid-CX3CR1+_Mac|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.90e-05 | 197 | 256 | 8 | 0e231b12881ab1f0f08040f248ea2e6fba34bc2f | |
| ToppCell | distal-Hematologic-IGSF21+_Dendritic-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.90e-05 | 197 | 256 | 8 | e77c91f5a1f5a292eda41abf3b1e31180f2c61e1 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-Myeloid-Microglia|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 1.97e-05 | 198 | 256 | 8 | c0d33629438504a1545e07f0e5af2e76f50fd55b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.97e-05 | 198 | 256 | 8 | 0a172c6d997c7cfbad34b56e80121bd104dee67d | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.97e-05 | 198 | 256 | 8 | 259fbcc0f2ac281a3e4d693de45b986fe5e24841 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-Myeloid|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 1.97e-05 | 198 | 256 | 8 | 2b93995f66c7352acc25d6c71d025b847881dacd | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_macrophage-stroma-stromal_macrophage|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.05e-05 | 199 | 256 | 8 | 2649afa3ccda78e9d1df26127b66cbfa0c6cd01d | |
| ToppCell | Bronchus_Control_(B.)-Immune-TX-MoAM-2|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 2.05e-05 | 199 | 256 | 8 | fb63885273d906a85fef178d859d20a311eb8a72 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.05e-05 | 199 | 256 | 8 | ca0f6526ba0dcf8789dd3b583291519626427f2f | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW23-Myeloid-Microglia|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 2.05e-05 | 199 | 256 | 8 | 4ddfbcaa8054b69b3398d8c0d5fab8ae94805cb9 | |
| ToppCell | COVID-19-COVID-19_Mild-Myeloid-immature_Neutrophil|COVID-19_Mild / Disease, condition lineage and cell class | 2.05e-05 | 199 | 256 | 8 | e222b90caf45904d8f763574e7b6aac13333df92 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.05e-05 | 199 | 256 | 8 | e1066e638af83ba5e89c7cabb8ad00b6bcdee5f4 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW23-Myeloid|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 2.05e-05 | 199 | 256 | 8 | 3ba48a4715d5e9387650aa97e0c5d7f7897bf380 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_I-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.12e-05 | 200 | 256 | 8 | a2548b0c77ba1616638351b111cce2fe0cacaa95 | |
| ToppCell | Macroglial-Astrocytes-SLC14A1---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 2.12e-05 | 200 | 256 | 8 | d6fcbf4f4bc1b89a9929d7b114c6b907b6979900 | |
| ToppCell | Severe_COVID-19-Myeloid-MoAM4|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 2.12e-05 | 200 | 256 | 8 | 30448a41ca64d6f0fedaff0b7a6670dd33cdf2c5 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM4-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.12e-05 | 200 | 256 | 8 | 4f481d87e30195365900acb5d50641a9e7b2f462 | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.12e-05 | 200 | 256 | 8 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.12e-05 | 200 | 256 | 8 | cf720d3973e79ffd4c6e763a7284799ced22a274 | |
| ToppCell | Macroglial-Astrocytes-SLC14A1----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 2.12e-05 | 200 | 256 | 8 | f861509b54185d89931db64da1b9d81986cc7938 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 2.12e-05 | 200 | 256 | 8 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM4-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.12e-05 | 200 | 256 | 8 | 5490393c5f54748f912676e19b58bd1320415a06 | |
| ToppCell | Parenchyma_Control_(B.)-Immune-TX-MoAM-2|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 2.12e-05 | 200 | 256 | 8 | 670ef1e68be0d2c6ea20ab4dea1d051a3cc89799 | |
| ToppCell | Macroglial-Astrocytes-SLC14A1|Macroglial / cells hierarchy compared to all cells using T-Statistic | 2.12e-05 | 200 | 256 | 8 | 16f468217427921fa18c6d078ffa990eb019b257 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_I|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.12e-05 | 200 | 256 | 8 | e4a499b69554f78161c2c47199da77c201910e73 | |
| ToppCell | Macroglial-Astrocytes-SLC14A1--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 2.12e-05 | 200 | 256 | 8 | 0442894c39eec69850c090957a5dc7bcecd21e04 | |
| ToppCell | COVID-19-Myeloid-MoAM2,_CCL18|COVID-19 / Condition, Lineage and Cell class | 2.12e-05 | 200 | 256 | 8 | b0a50622d00335843efad86bc56a1e910019984b | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM4|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.12e-05 | 200 | 256 | 8 | df821ac12953e44fcfedbbefb35a4976e406ccd6 | |
| ToppCell | Macroglial-Astrocytes-SLC14A1-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 2.12e-05 | 200 | 256 | 8 | 01819446deeab9054f5cfe889d53bb49d137dbc0 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.20e-05 | 146 | 256 | 7 | 2ac9b487a7991fdc15444aeb93533030e09825bb | |
| ToppCell | remission-multiplets|remission / disease stage, cell group and cell class | 2.51e-05 | 149 | 256 | 7 | e9974260a5f2999b363f306cae005698c912893a | |
| ToppCell | PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.12e-05 | 161 | 256 | 7 | 8937f6b92cb2a93ea8c4780d9200a518c3112e53 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 4.28e-05 | 162 | 256 | 7 | 810881210e015c788814e4fe8d7a24c929cf2621 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.63e-05 | 164 | 256 | 7 | 54f8f11d2fa899005530c08e7a1ee728c7b0799c | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l15|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.11e-05 | 114 | 256 | 6 | 84318a25a701331ccd5e68221239c543b9c0cc54 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.20e-05 | 167 | 256 | 7 | 942134bbabe9972fae80cbc4ed4e94da52f55dc3 | |
| ToppCell | droplet-Fat-Bat-18m-Myeloid-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.40e-05 | 168 | 256 | 7 | 6fddc957a0503455d8c165862b5eb8e5fdb8a510 | |
| ToppCell | droplet-Fat-Bat-18m-Myeloid-myeloid_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.40e-05 | 168 | 256 | 7 | 794035cb63353a7d02fd9939deb5b4d075c9d95a | |
| ToppCell | droplet-Fat-Bat-18m-Myeloid|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.40e-05 | 168 | 256 | 7 | 1e23b634f96e88b976a523ca1f3fc08f6fe9b239 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.60e-05 | 169 | 256 | 7 | 20fbf78382fb0ba9a63ab1aa0abc615476994ac5 | |
| ToppCell | 3'_v3-Lung-Myeloid_Mac-Intestinal_macrophages|Lung / Manually curated celltypes from each tissue | 5.60e-05 | 169 | 256 | 7 | 241644823e6f949aaf4c671d4579721d7ef6b0e5 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar-Macro_c3-EREG|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.81e-05 | 170 | 256 | 7 | 9ac1ef57f14418a5dd2aa16861c3df698c28f5ed | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Non-keratinizing_Cervical_Squamous_Cell_Carcinoma-2|TCGA-Cervix / Sample_Type by Project: Shred V9 | 6.49e-05 | 119 | 256 | 6 | d21877baa088440a1e1902bbeb667b977475437a | |
| Disease | aflatoxins-related hepatocellular carcinoma (biomarker_via_orthology) | 1.88e-05 | 7 | 243 | 3 | DOID:5022 (biomarker_via_orthology) | |
| Disease | alcohol dependence (biomarker_via_orthology) | 3.00e-05 | 8 | 243 | 3 | DOID:0050741 (biomarker_via_orthology) | |
| Disease | choroideremia (implicated_via_orthology) | 6.75e-05 | 2 | 243 | 2 | DOID:9821 (implicated_via_orthology) | |
| Disease | metabolite measurement | FAM47A CYP2C8 NCBP1 GCH1 ELOVL2 SLC12A5 STAB1 SLIT2 GLYATL3 CYP4F2 NBAS CGREF1 ZMYM1 HSD17B14 PRODH | 7.06e-05 | 560 | 243 | 15 | EFO_0004725 |
| Disease | amino acid measurement | ERBB4 SETX TGM5 RYR3 SLIT2 PASK SCN4A C5 FLRT2 PLXNA2 GCFC2 VWF NBAS SLIT1 LRBA PRODH | 1.75e-04 | 678 | 243 | 16 | EFO_0005134 |
| Disease | complement C5B-C6 complex measurement | 2.02e-04 | 3 | 243 | 2 | EFO_0020279 | |
| Disease | Colorectal Carcinoma | ERCC6 ABCA13 PAK6 SLC12A5 ABCC8 OR1E2 RALGDS DONSON ANK2 SELENBP1 LAMC1 APOB ADAMTSL3 GMCL2 LIG3 ABCB10 | 2.59e-04 | 702 | 243 | 16 | C0009402 |
| Disease | atrial fibrillation | USP34 MYH7 ERBB4 ARHGAP26 BEST3 CATSPER3 SLC24A4 ARHGAP10 GMCL1 SLIT1 XPO7 | 2.78e-04 | 371 | 243 | 11 | EFO_0000275 |
| Disease | familial atrial fibrillation | 3.24e-04 | 156 | 243 | 7 | C3468561 | |
| Disease | Persistent atrial fibrillation | 3.24e-04 | 156 | 243 | 7 | C2585653 | |
| Disease | Paroxysmal atrial fibrillation | 3.24e-04 | 156 | 243 | 7 | C0235480 | |
| Disease | factor VIII measurement | 3.25e-04 | 40 | 243 | 4 | EFO_0004630 | |
| Disease | Atrial Fibrillation | 3.78e-04 | 160 | 243 | 7 | C0004238 | |
| Disease | dedicator of cytokinesis protein 9 measurement | 4.01e-04 | 4 | 243 | 2 | EFO_0801521 | |
| Disease | X-linked mental retardation with cerebellar hypoplasia and distinctive facial appearance (implicated_via_orthology) | 4.01e-04 | 4 | 243 | 2 | DOID:0080311 (implicated_via_orthology) | |
| Disease | hypertension (biomarker_via_orthology) | 6.21e-04 | 227 | 243 | 8 | DOID:10763 (biomarker_via_orthology) | |
| Disease | erythrocyte band 7 integral membrane protein measurement | 6.64e-04 | 5 | 243 | 2 | EFO_0801584 | |
| Disease | Lupus Erythematosus, Discoid | 6.64e-04 | 5 | 243 | 2 | C0024138 | |
| Disease | liver fibrosis measurement | 7.36e-04 | 86 | 243 | 5 | EFO_0010576 | |
| Disease | e-selectin measurement | 7.57e-04 | 22 | 243 | 3 | EFO_0004575 | |
| Disease | galectin-7 measurement | 9.91e-04 | 6 | 243 | 2 | EFO_0022034 | |
| Disease | familial combined hyperlipidemia (is_marker_for) | 9.91e-04 | 6 | 243 | 2 | DOID:13809 (is_marker_for) | |
| Disease | paroxysmal nocturnal hemoglobinuria (is_implicated_in) | 9.91e-04 | 6 | 243 | 2 | DOID:0060284 (is_implicated_in) | |
| Disease | Small cell carcinoma of lung | 1.03e-03 | 54 | 243 | 4 | C0149925 | |
| Disease | ecosanoids measurement | 1.10e-03 | 55 | 243 | 4 | EFO_0020044 | |
| Disease | response to peginterferon alfa-2a | 1.11e-03 | 25 | 243 | 3 | EFO_0010103 | |
| Disease | colon adenocarcinoma (is_implicated_in) | 1.25e-03 | 26 | 243 | 3 | DOID:234 (is_implicated_in) | |
| Disease | omega-6 polyunsaturated fatty acid measurement | 1.29e-03 | 197 | 243 | 7 | EFO_0005680 | |
| Disease | septic shock | 1.38e-03 | 7 | 243 | 2 | EFO_0006834 | |
| Disease | LDL cholesterol change measurement | 1.38e-03 | 7 | 243 | 2 | EFO_0007804 | |
| Disease | tumor necrosis factor ligand superfamily member 6, soluble form measurement | 1.38e-03 | 7 | 243 | 2 | EFO_0020797 | |
| Disease | hepatitis C virus infection, cirrhosis of liver | 1.38e-03 | 7 | 243 | 2 | EFO_0001422, EFO_0003047 | |
| Disease | coronary artery disease, plasminogen activator inhibitor 1 measurement | 1.83e-03 | 63 | 243 | 4 | EFO_0001645, EFO_0004792 | |
| Disease | esterified cholesterol measurement, intermediate density lipoprotein measurement | 1.83e-03 | 8 | 243 | 2 | EFO_0008589, EFO_0008595 | |
| Disease | obsolete_red blood cell distribution width | MYCL CYP2C18 SLC22A23 SLC6A19 ITGAX ABCA7 ARL17A LONP1 NFE2L1 CLUH DIP2B RALGDS SELENBP1 LPAR5 APOB GMCL1 LOXHD1 RUVBL1 GYPB ARHGAP27 STKLD1 OR51V1 | 1.84e-03 | 1347 | 243 | 22 | EFO_0005192 |
| Disease | serum metabolite measurement | CYP2C8 CYP2C18 ZNF862 PKD1L1 BCAT1 SLC24A3 GCH1 ABCA7 ELOVL2 GGT1 SLIT2 CYP4F2 APOB CELSR2 SORCS3 HAL PRODH | 2.28e-03 | 945 | 243 | 17 | EFO_0005653 |
| Disease | epilepsy (implicated_via_orthology) | 2.38e-03 | 163 | 243 | 6 | DOID:1826 (implicated_via_orthology) | |
| Disease | factor VIII measurement, coronary artery disease | 2.48e-03 | 113 | 243 | 5 | EFO_0001645, EFO_0004630 | |
| Disease | mean reticulocyte volume | NUP210L ABCA7 LONP1 TMEM131L TMCO3 LPAR5 C6orf89 NPEPPS NLRX1 RTTN AIP GTF3C1 GYPB CLINT1 XPO7 | 2.74e-03 | 799 | 243 | 15 | EFO_0010701 |
| Disease | parental longevity | ERBB4 PLXNB2 RYR3 ABCC8 DHODH BSN ANK2 C6orf89 LAMC1 CELSR2 GALNTL5 | 2.80e-03 | 494 | 243 | 11 | EFO_0007796 |
| Disease | tissue plasminogen activator measurement, coronary artery disease | 2.83e-03 | 71 | 243 | 4 | EFO_0001645, EFO_0004791 | |
| Disease | von Willebrand factor measurement, coronary artery disease | 2.99e-03 | 118 | 243 | 5 | EFO_0001645, EFO_0004629 | |
| Disease | duodenal ulcer | 3.22e-03 | 36 | 243 | 3 | EFO_0004607 | |
| Disease | Cataract | 3.49e-03 | 37 | 243 | 3 | C0086543 | |
| Disease | gastric adenocarcinoma (is_implicated_in) | 3.54e-03 | 11 | 243 | 2 | DOID:3717 (is_implicated_in) | |
| Disease | pro‐interleukin‐16 measurement | 3.54e-03 | 11 | 243 | 2 | EFO_0010629 | |
| Disease | Malignant neoplasm of breast | ERBB4 ERCC6 ACO2 BARD1 DYSF PGR FASN SERPINE2 UTP20 FASTKD3 VWF ANK2 ARFGEF2 SLAMF1 MOSPD1 ABCB10 LRBA PRODH | 3.62e-03 | 1074 | 243 | 18 | C0006142 |
| Disease | asthma | ACO2 ETF1 DYSF STAT6 SLC24A4 AP2A2 COL15A1 C6orf89 HEATR5A GSAP ADAMTSL3 GYPB UBAC2 ARHGAP27 | 3.99e-03 | 751 | 243 | 14 | MONDO_0004979 |
| Disease | cesarean section, intelligence | 4.22e-03 | 12 | 243 | 2 | EFO_0004337, EFO_0009636 | |
| Disease | distal myopathy (implicated_via_orthology) | 4.22e-03 | 12 | 243 | 2 | DOID:11720 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of prostate | MYCL CYP2C18 RPN2 NDST4 PAK6 GGT1 CCHCR1 MYBBP1A COL15A1 LAMC1 TLR5 TPBG | 5.33e-03 | 616 | 243 | 12 | C0376358 |
| Disease | Prostatic Neoplasms | MYCL CYP2C18 RPN2 NDST4 PAK6 GGT1 CCHCR1 MYBBP1A COL15A1 LAMC1 TLR5 TPBG | 5.33e-03 | 616 | 243 | 12 | C0033578 |
| Disease | erythrocyte measurement | 5.62e-03 | 257 | 243 | 7 | EFO_0005047 | |
| Disease | esterified cholesterol measurement, low density lipoprotein cholesterol measurement | 5.76e-03 | 14 | 243 | 2 | EFO_0004611, EFO_0008589 | |
| Disease | Hereditary Breast and Ovarian Cancer Syndrome | 5.76e-03 | 14 | 243 | 2 | C0677776 | |
| Disease | Kartagener syndrome (implicated_via_orthology) | 5.76e-03 | 14 | 243 | 2 | DOID:0050144 (implicated_via_orthology) | |
| Disease | atrial fibrillation (is_implicated_in) | 5.76e-03 | 14 | 243 | 2 | DOID:0060224 (is_implicated_in) | |
| Disease | CD209 antigen measurement | 5.76e-03 | 14 | 243 | 2 | EFO_0008077 | |
| Disease | phoneme awareness | 5.76e-03 | 14 | 243 | 2 | EFO_0021812 | |
| Disease | Thrombus | 6.45e-03 | 46 | 243 | 3 | C0087086 | |
| Disease | non-high density lipoprotein cholesterol measurement | USP34 WDR81 PLXNA3 DIP2B NPEPPS ARFGEF2 LAMC1 APOB HEATR5A CELSR2 TAMM41 CMTM7 DNAH11 | 6.52e-03 | 713 | 243 | 13 | EFO_0005689 |
| Disease | brain edema (biomarker_via_orthology) | 6.61e-03 | 15 | 243 | 2 | DOID:4724 (biomarker_via_orthology) | |
| Disease | response to statin, LDL cholesterol change measurement | 6.61e-03 | 15 | 243 | 2 | EFO_0007804, GO_0036273 | |
| Disease | Hypertriglyceridemia | 6.61e-03 | 15 | 243 | 2 | C0020557 | |
| Disease | myopia (is_implicated_in) | 7.51e-03 | 16 | 243 | 2 | DOID:11830 (is_implicated_in) | |
| Disease | resting metabolic rate measurement | 7.51e-03 | 16 | 243 | 2 | EFO_0008004 | |
| Disease | sickle cell anemia (is_implicated_in) | 7.51e-03 | 16 | 243 | 2 | DOID:10923 (is_implicated_in) | |
| Disease | Thrombosis | 7.69e-03 | 49 | 243 | 3 | C0040053 | |
| Disease | blood copper measurement | 8.13e-03 | 50 | 243 | 3 | EFO_0007578 | |
| Disease | diabetic nephropathy | 8.19e-03 | 150 | 243 | 5 | EFO_0000401 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SYLPAANRLLVVLIK | 296 | Q7L8C5 | |
| ISLVYRLLLTGVQKR | 46 | Q8N1M1 | |
| LLVTRLQKALGVRQY | 6 | Q99798 | |
| RVLYSGLSLLILKQQ | 426 | Q15303 | |
| AVLYLERAGQLSVKL | 136 | P07360 | |
| LELYLARVSKGQASL | 331 | Q96FG2 | |
| LASRILSKLTDIQYG | 361 | P54687 | |
| KLLLSYGASRNAVNI | 511 | Q99728 | |
| YVVEALLKIIALGLS | 491 | Q8NEC5 | |
| LRILKLIGYSQGIRT | 151 | Q86XQ3 | |
| GALYRKTSQLLETLN | 1146 | Q14203 | |
| SIILLGFISLDRYIK | 141 | Q9UPC5 | |
| GYVLSASAVQLILKV | 266 | O96024 | |
| LKNTYSGLQLIIVIL | 506 | Q9UL18 | |
| LAQLIGTGVKTRYLS | 1001 | Q9Y6D5 | |
| LSVIIAKNGSLQIRY | 1066 | Q9C0A0 | |
| TTSTTLRYGLLLLLK | 301 | P10632 | |
| KQSLSRLAAYLRGLE | 2861 | Q96DT5 | |
| LKEAYGQGLRLTLTR | 4061 | Q86UQ4 | |
| SGKSTVLSLLLRLYD | 531 | Q9NRK6 | |
| LILSLDTAGKTTILY | 21 | Q8IVW1 | |
| VVLLLLQGGSAYKLV | 16 | Q15782 | |
| IDYLGRSALILAVTL | 181 | Q8N2N9 | |
| LKTLTYVALGVTLAA | 2376 | Q9HCU4 | |
| LQSYLKGLGRTEVQL | 51 | Q99674 | |
| LAYQLSKLGVSLVLS | 66 | Q9Y394 | |
| RKLIELNYLGTVSLT | 156 | Q9Y394 | |
| IISLGLYSQVSKLLA | 21 | O43155 | |
| GLLIQALKVNLSDYI | 506 | Q86XH1 | |
| QIIAFLAGLSYSKIR | 541 | Q03468 | |
| VIGLTFRKDLYVQTL | 66 | P36575 | |
| LLLKYREGRTLILST | 981 | Q8IZY2 | |
| VLYPLVAKSLRNIAV | 96 | O00170 | |
| SKFYSQLIVRGVLGL | 91 | Q9BV10 | |
| LLGSIILALLQRKNY | 161 | Q16671 | |
| TRALLLSTYIKFVNL | 536 | O94973 | |
| KLICSRTTGYQILTL | 466 | Q96IK5 | |
| VKINSRGLVYSVVLL | 551 | Q8NFF2 | |
| KYLTEGLLQFTILLS | 6 | Q14494 | |
| ARLRALNGLLYKALT | 91 | Q8N0V3 | |
| LVSKLLYSRGLLIDL | 231 | P24386 | |
| LYSRGLLIDLLIKSN | 236 | P24386 | |
| IDLVSKLLYSQGLLI | 231 | P26374 | |
| SYKALVALRRVLLAQ | 46 | O75771 | |
| SALLSLLGDLKVRYV | 651 | Q6ZP01 | |
| GLLLLALITAVLYKV | 1116 | P20702 | |
| ITLLGVVYKRLIALS | 496 | Q8NHS3 | |
| ALISQLTRGKLTYTQ | 1296 | P12883 | |
| QTVTRLLYGFLIKAN | 516 | Q92542 | |
| LKTARTLSLFYGVNV | 346 | Q86VD1 | |
| TALAIAKRLGYISVV | 796 | Q01484 | |
| SYGQKLSKLAILRIA | 261 | Q96SQ7 | |
| LYRVVGVSSKVQRLL | 416 | A1A4S6 | |
| LALILNILKGYNFSR | 286 | A6NGU5 | |
| YVIILRSLKNNSLEG | 216 | Q96R67 | |
| QLVSAVGYLRLKDII | 1111 | Q96RG2 | |
| YISGLLNDIQKLSVI | 81 | Q9NQU5 | |
| INIFLYILTIIGRAK | 356 | Q7Z429 | |
| RKVYSILSLQVLLTT | 36 | Q9HC24 | |
| LYGLTNTLRLRLKLT | 496 | Q9P2G4 | |
| KSLLLLAYLIRNGSE | 81 | Q14677 | |
| NSTLAVYGLLRSKLV | 251 | Q9H1C0 | |
| EKLTIYTTLVGLLNA | 81 | Q09161 | |
| GLILYISLAIRKRVQ | 516 | Q12866 | |
| GTIILKLYRVLQLFL | 461 | Q6PRD1 | |
| VIGSISSVLYLLSRL | 186 | Q6ZP29 | |
| LNLIKGTRSAAYERL | 221 | Q9NUN5 | |
| RLVYLLTDKTGTLTQ | 461 | O43861 | |
| RKLLGNVSLSLLYKS | 16 | Q53G44 | |
| NVGLILTLVLNRLYK | 51 | Q2LD37 | |
| TIYAIDLGALTKIRI | 871 | Q8IVV2 | |
| LTSLAVEARKYGLAL | 1686 | Q9UPA5 | |
| YLFLGSRLGNSLLLK | 381 | Q10570 | |
| SEIYLTRLLATKGTL | 1676 | Q9UIW2 | |
| IYLTRLLATKGTLQK | 1676 | O75051 | |
| SEIYLTRLLATKGTL | 1651 | P51805 | |
| IYLTRLLATKGTLQK | 1676 | Q9HCM2 | |
| AITEIYLTRLLSVKG | 1616 | O15031 | |
| YLTRLLSVKGTLQQF | 1621 | O15031 | |
| EIYLTRLLSTKGTLQ | 1701 | Q9Y4D7 | |
| DGSYLNKLLITRARQ | 316 | Q8N441 | |
| DLSRNLITSLKGIQY | 56 | Q1X8D7 | |
| ISFSYLLILKTVLGL | 216 | Q8TCB6 | |
| IVISYTLILKNILGT | 216 | Q8NH59 | |
| YSSILTNSRIIKIGL | 141 | Q9H2C8 | |
| LNVALVALVLLGAYR | 56 | O15173 | |
| SRSLKLAYTLLNKLG | 376 | Q9P265 | |
| LSVNQKLVAAYILGL | 191 | Q9UJG1 | |
| KTLDLSGIRLTNYSL | 326 | P0DUQ1 | |
| LGVLASYNLTVRELK | 156 | P50851 | |
| LTLLIKQYCRESGVR | 696 | P36776 | |
| GVLTRLVLVNAVYFK | 176 | P07093 | |
| VQTVTGGLRSLYLRK | 21 | Q9H223 | |
| LAALYIVLGLRKTTL | 501 | Q86UT6 | |
| LSGKRLTLSLDRYIL | 291 | Q9H3R1 | |
| AVSYTLILKTVLGIA | 216 | Q8NGJ6 | |
| SISFLGLITIDRYQK | 111 | Q9H244 | |
| TKVLLDIFTGVRLYL | 931 | P49916 | |
| VLAVLNLLYVFSKRS | 131 | Q7Z6Z7 | |
| YKQSTKLLGLAELLR | 1256 | A2RRP1 | |
| LRVDIKAYLGSAIQL | 246 | Q9Y3T9 | |
| NLGASYRKLISLKIT | 351 | Q86Y13 | |
| LNSRGLIYSVGLLLA | 576 | Q9HC58 | |
| LLSGRAYIVTKGQLL | 341 | Q9NZU5 | |
| ASLYLLRVLKGNTAE | 926 | Q9BQG0 | |
| TNLKVSGALYREITL | 826 | Q8NB91 | |
| AALVGSIYSLISLLK | 46 | Q86SP6 | |
| SSYIRELIKAIGLRQ | 846 | P06401 | |
| YSRLVALTLARKLQS | 226 | Q5SZD4 | |
| TRIFLLGLSIKLNGY | 186 | O43825 | |
| LGLSIKLNGYLQRAI | 191 | O43825 | |
| ALYGNLILRKGVLAL | 136 | A2VDF0 | |
| GTILLISYSIRRLIK | 76 | P06028 | |
| GKLYRALLSQSSLLQ | 401 | A4D1B5 | |
| GYTLRLEQAATLKAL | 51 | Q08828 | |
| TYILNIKRGIISALL | 151 | P04114 | |
| TVYRILAETLGNLQK | 1761 | Q9C0G6 | |
| LINGLYTNRTVIKAT | 2236 | Q6WRI0 | |
| LALRINVLAKGYSGI | 211 | P42357 | |
| YDVRISVSKLLGIIL | 226 | Q86XA9 | |
| ELGLGKLLNRYLIIA | 671 | P16383 | |
| ALSLRGILTLYNLGI | 61 | Q9NXB9 | |
| LQIKILRLGGIAYFL | 641 | Q9H2U1 | |
| VVKLLVRLSDSVGYL | 346 | Q96PZ2 | |
| TLIAQSSKSLRYLGL | 636 | Q9UF56 | |
| SLYLTAFTVIGIRKA | 1141 | P01031 | |
| GLTEYSLLVKQLRLS | 1296 | P01031 | |
| LLTRNLTAYRKELVG | 116 | Q92828 | |
| QAVVRLKSVQGLYLL | 61 | Q9NQT6 | |
| ATVYLQILRLKPLTG | 191 | O95390 | |
| ELLKYGFNVIISRSL | 96 | Q7Z4T8 | |
| ILRVYSGILNQSEIK | 441 | P03951 | |
| GLLSRYKQQRLLTVL | 691 | Q8TD31 | |
| LLVILLSYVGTLQKV | 61 | Q9Y5Q5 | |
| YIAAILELSALVSKR | 221 | P78329 | |
| LYSGILINIKSALSQ | 2851 | Q0VDD8 | |
| LLRISKNGKVLYSIR | 151 | P23416 | |
| KNGKVLYSIRLTLTL | 156 | P23416 | |
| LINGVIYSISLRKVQ | 71 | Q12967 | |
| YTRKLLGSALALARA | 41 | P04839 | |
| LELNLLGTYTLTKLA | 111 | Q9BPX1 | |
| LLGKSSLRNVVLRDY | 546 | Q9NYP3 | |
| VSNLLLYILKVLDSG | 421 | Q5JRC9 | |
| AQLKLVALDGLLYAI | 396 | Q96G42 | |
| KLLNNLTSIKIRGTY | 646 | P11047 | |
| TTSTTLRYGLLLLLK | 301 | P33260 | |
| YIAAILELSALVTKR | 221 | Q08477 | |
| LTKFLYVLRGLLRTS | 281 | Q96EB1 | |
| VYKVLATLGLILLTA | 61 | Q6UWU4 | |
| TLAYVISLQGARKLL | 496 | Q8NBJ5 | |
| YTKILQALNIRIGTR | 231 | Q99680 | |
| KSLARRVYATILNAG | 236 | P49327 | |
| TDAFQKVIYLGLRLS | 111 | P39059 | |
| LIQQRAVLRVSYKGS | 76 | Q6SPF0 | |
| VRSIKVSGYLNLLAN | 211 | Q96H72 | |
| AYRGRLLLSLETKLV | 551 | O75923 | |
| ELLSNLYDKLGRLLT | 441 | O94829 | |
| LILKYTRALLAQGQF | 1391 | Q8TDX9 | |
| RYQGGFLISRLIKLS | 841 | P55786 | |
| LALILNILKGYNFSR | 286 | P36268 | |
| KDYTANRLVSGLLQL | 436 | Q9BTE3 | |
| SAILKRFTGSYQILL | 1801 | Q5VU65 | |
| LLILGSYARIVSSIL | 221 | P47887 | |
| TFLTIYLVTLKGNSL | 31 | Q9H207 | |
| YLVTLKGNSLIILVT | 36 | Q9H207 | |
| VILSILAIYAGVIKS | 286 | Q9H2X9 | |
| SNIQKLRILYGVLFL | 16 | Q96R54 | |
| IISLIAGIAVLRSLY | 146 | Q6IFG1 | |
| LLLISYGVILNSLKT | 211 | P0C604 | |
| VNTAAKAILLYLLQG | 686 | Q86VV8 | |
| LLYVLKELQTTLVRG | 1881 | O75691 | |
| YVVLTIFLIRGLTLK | 231 | Q695T7 | |
| TLLLETIILGKQYSL | 131 | Q76EJ3 | |
| TIILGKQYSLNIILS | 136 | Q76EJ3 | |
| GKTLLFVRLLTGLYR | 76 | Q9Y5M8 | |
| LSIVGLALSDLIQKY | 1426 | P35499 | |
| LVLSLILPRSSQYIK | 596 | Q6UWJ1 | |
| DYGKVTSLILIRNNL | 696 | A2VDJ0 | |
| KTGLSLEVATYRALL | 301 | O15061 | |
| ATGSRVLNKNYTLLV | 131 | P0C866 | |
| KILIYGNISFRLGVL | 166 | Q9H9A7 | |
| ILILTKLYDFNLGSV | 211 | Q9UPU3 | |
| ASLLQLGLLNLIGKY | 506 | A1A5C7 | |
| SREILINLIQAYKGL | 171 | Q15573 | |
| KIGLTNLLGARLYFA | 541 | Q14CZ7 | |
| QVLGLSKLARIVEIY | 161 | P30793 | |
| KLVCSRTTGYQILIL | 466 | Q8NEA9 | |
| GNSNLVYAIIRKRSI | 546 | Q8IV36 | |
| YNTKRGIVASILVFL | 91 | Q9BVG9 | |
| ALEKIRAGASLVQLY | 341 | Q02127 | |
| YRIVGVNSRVQKLLS | 411 | Q9UNA1 | |
| LYRISGNLATIQKLR | 731 | Q6ZUM4 | |
| KTLDLSGIRLTNYSL | 326 | A6NGN4 | |
| QLLYVSRKLLGQRLF | 91 | O43272 | |
| LRQLGSKVLLPLTYE | 36 | Q13291 | |
| KTIVGLLYRLLTENQ | 1971 | Q7Z333 | |
| LYGSRQEALILIKGS | 66 | Q9ULL8 | |
| DRLLKVLFLVLGYTV | 291 | Q9BRY0 | |
| QLSLDGKRLYITTSL | 391 | Q13228 | |
| KTLDLSGIRLTNYSL | 326 | A3QJZ7 | |
| VLLKGILTNGLVSVY | 976 | Q8NHU6 | |
| TFLRVVGSELIQKYL | 246 | P62191 | |
| TAEALLYGILQLQRK | 186 | O75251 | |
| INYRTAIRLKVALST | 186 | Q96J65 | |
| KGLSLSYIIQLSGLL | 1056 | Q96J65 | |
| TQRYLALSARLEKLG | 251 | Q9H0A9 | |
| LTKLQEYLSGRSILA | 441 | P98171 | |
| AVAYLLNLVLKRVPS | 166 | Q5JTH9 | |
| ALLPGKRYTIQLTTL | 1066 | Q8TER0 | |
| AKYLSSAGILLLSLL | 1001 | Q09428 | |
| LAASGGYVNIIKILL | 1161 | Q8IWZ3 | |
| LLLLIASIVAASKSY | 121 | Q96FZ5 | |
| TYGLQKITLLREISL | 921 | O75153 | |
| QLSKLADRIQLSGRY | 671 | Q9Y4G8 | |
| KTLDLSGIRLTNYSL | 326 | O60810 | |
| LYRELDLNSVLLKLG | 141 | O00584 | |
| AITATLEGKNRTLYL | 401 | Q8TBC4 | |
| VESGRYIILLLGKAL | 956 | P04275 | |
| VILSKALEYLQALVG | 321 | P12524 | |
| KALGQLISKYSLREL | 71 | Q969N2 | |
| LSTSKGLIAGNLRYI | 171 | Q9Y5K1 | |
| SGYLQAQLLRLTIGK | 346 | Q9H5L6 | |
| VGYLIRLSIKSIQIE | 281 | Q7RTY8 | |
| QTLKYLAILGSVTFL | 601 | P04844 | |
| LLVNNAYRGLASLVK | 561 | Q8NE28 | |
| VLSATILYEILLGKA | 141 | P01850 | |
| LLGKATLYAVLVSAL | 151 | P01850 | |
| LIDSTLQTIYRLSKG | 2441 | Q15413 | |
| CLLKLQVSSQRTGLY | 46 | P38935 | |
| RLIIGFISKQYVTSL | 536 | P42226 | |
| KLVQSTLSDLRVYLG | 116 | Q9BYN0 | |
| KTLDLSGIRLTNYSL | 326 | P0DUQ2 | |
| LYKVNGILTLATFLS | 176 | Q8TBR7 | |
| VIILSGILQLYFLKR | 211 | Q8WW62 | |
| QYGLLKILSKTLAAL | 1551 | Q5SRE5 | |
| KTLDLSGIRLTNYSL | 326 | O60813 | |
| YLFTAGLSKLQELVR | 561 | Q9NY15 | |
| GLRSLNSLVLYGNKI | 346 | O94813 | |
| ILVFRSKTYGNVLVL | 51 | P19623 | |
| QYLSTDKLIRISALG | 586 | O43548 | |
| RLIKYGVISTNVLIE | 106 | Q96BW9 | |
| EIGTKTTLRYSVQLL | 396 | Q9Y265 | |
| EILLGKATLYAVLVS | 286 | P0DTU4 | |
| ILTTYTGQLFCLRKL | 1156 | Q9P2E3 | |
| LLQSTGTVILGKYRN | 581 | O60290 | |
| ALQSLRFRVKLYGLS | 111 | Q9H0C1 | |
| VLSDIKSIGLYLRSQ | 1406 | Q86YA3 | |
| LLNDLSIGYSSVRKL | 616 | Q9UIA9 | |
| IATILQSTLKGLEYL | 126 | Q13043 | |
| YFGLISLKVLNSIVL | 436 | Q6NXT6 | |
| IGAIFLLVLYLNRKG | 366 | Q13641 | |
| VLSATILYEILLGKA | 141 | A0A5B9 | |
| LLGKATLYAVLVSAL | 151 | A0A5B9 | |
| YRVLSVTGILSKELQ | 866 | Q5SVZ6 | |
| NKTLIYILGLQLFTS | 161 | Q8NBM4 | |
| QVYNVLLGLLSRAKL | 2726 | Q70CQ2 | |
| LLGLLSRAKLYVDAA | 2731 | Q70CQ2 | |
| LLRLYRTTVIQDGIK | 671 | Q12789 | |
| NLRILDLGSSKIYFL | 96 | O60602 | |
| TVALFLLEIRGYSKL | 91 | O75845 | |
| LRSLNSLVLYGNKIT | 356 | O75093 | |
| VLYLKVAELLSSGLQ | 901 | O75385 | |
| GLLAAVTLTQKIIVY | 1341 | Q562E7 | |
| LTIGSNLSIRIAAYK | 251 | P13010 | |
| GQKSARLDLLYRLLT | 1246 | O95071 | |
| DLLTGYSKLIQSRLK | 21 | Q9UFV3 | |
| EKRINLTIGSRAYLL | 911 | P82987 | |
| VLGAITSVQQRLKLY | 71 | P62495 | |
| LALILNILKGYNFSR | 286 | P19440 | |
| GLAIALQAYSKRLLR | 641 | P23276 |